Loading...
Loading...
India's emtricitabine imports from UNITED STATES total $942.1K across 52 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $481.3K in import value; the top 5 suppliers together control 76.7% of this origin. Leading Indian buyers include LUPIN LIMITED. This corridor reflects India's pharmaceutical import demand for emtricitabine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Emtricitabine supplier from UNITED STATES to India, with import value of $481.3K across 15 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC, ESPEE BIOPHARMA & FINECHEM LLC., NewLife Medicals (USA). Inc., PREMIUM HEALTH SERVICES,INC. — collectively account for 76.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $481.3K | 15 | 51.1% |
| 2 | Espee Biopharma & Finechem LLC | $92.9K | 7 | 9.9% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC. | $59.7K | 1 | 6.3% |
| 4 | NewLife Medicals (USA). Inc. | $44.5K | 1 | 4.7% |
| 5 | PREMIUM HEALTH SERVICES,INC. | $44.2K | 1 | 4.7% |
| 6 | AGRACE PHARMA | $39.0K | 3 | 4.1% |
| 7 | PREMIUM HEALTH SERVICES INC | $32.5K | 1 | 3.5% |
| 8 | AGRACE PHARMA. | $25.3K | 3 | 2.7% |
| 9 | NEWLIFE MEDICALS (USA) INC | $24.3K | 1 | 2.6% |
| 10 | PREMIUM HELTH SERVICES INC, | $19.9K | 1 | 2.1% |
| 11 | AMSTERDAM PHARMA(APTEKA RX INC.) | $14.0K | 3 | 1.5% |
| 12 | Pharmaceutical Buyers Inc | $13.9K | 1 | 1.5% |
| 13 | PHARMACEUTICAL BUYER .INC | $11.9K | 1 | 1.3% |
| 14 | NEW LIFE MEDICALS (USA) INC | $9.9K | 1 | 1.0% |
| 15 | M/S. ESPEE BIOPHARMA & FINECHEM LLC | $9.3K | 2 | 1.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LUPIN LIMITED | $192.9K | 4 | 20.5% |
| 2 | MYLAN LABORATORIES LIMITED | $171.4K | 11 | 18.2% |
| 3 | LAURUS LABS LIMITED | $141.4K | 5 | 15.0% |
| 4 | HETERO LABS LIMITED | $69.0K | 6 | 7.3% |
| 5 | LAURUS LABS LTD | $64.1K | 1 | 6.8% |
| 6 | MICRO LABS LIMITED | $59.7K | 1 | 6.3% |
| 7 | EMCURE PHARMACEUTICALS LIMITED | $51.6K | 3 | 5.5% |
| 8 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $44.0K | 2 | 4.7% |
| 9 | MACLEODS PHARMACEUTICALS LIMITED | $26.4K | 1 | 2.8% |
| 10 | DR.REDDY'S LABORATORIES LTD | $25.3K | 3 | 2.7% |
| 11 | AUROBINDO PHARMA LIMITED | $24.3K | 1 | 2.6% |
| 12 | CLIANTHA RESEARCH LIMITED | $19.9K | 1 | 2.1% |
| 13 | AUROBINDO PHARMA LTD | $14.0K | 3 | 1.5% |
| 14 | CIPLA LIMITED | $12.0K | 3 | 1.3% |
| 15 | AJANTA PHARMA LIMITED | $9.9K | 1 | 1.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Emtricitabine suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC, ESPEE BIOPHARMA & FINECHEM LLC.. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $481.3K USD across 15 shipments. India imported Emtricitabine worth $942.1K USD from UNITED STATES in total across 52 shipments.
India imported Emtricitabine worth $942.1K USD from UNITED STATES across 52 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Emtricitabine sourced from UNITED STATES include LUPIN LIMITED, MYLAN LABORATORIES LIMITED, LAURUS LABS LIMITED. The largest buyer is LUPIN LIMITED with $192.9K in imports across 4 shipments.
The total value of Emtricitabine imports from UNITED STATES to India is $942.1K USD, across 52 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
52 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists